Is Transgender Sport Participation Killing Women's Sports?

In March 2022, Lia Thomas became the first transgender woman to win an NCAA Division I national championship in swimming, winning the 500-yard freestyle. Prior to transitioning, Thomas competed on the men's team at the University of Pennsylvania, ranking 462nd nationally in the 500-yard freestyle in the 2018-19 season. After transitioning and undergoing testosterone suppression for over a year, Thomas won the event by 1.75 seconds, prompting criticisms that retained biological advantages from male puberty (e.g., bone density, lung capacity, and muscle mass) create an unfair playing field. The case catalyzed policy changes, including World Aquatics' 2022 rule banning transgender women from elite women's competitions if they underwent male puberty, and the NCAA's subsequent sport-specific eligibility standards.

A 2020 study published in the Journal of Medical Ethics analyzed U.S. Air orce personnel data and found that transgender women who underwent at least 12 months of testosterone suppression retained significant performance advantages over cisgender women: a 12% advantage in push-ups and a 21% advantage in sit-ups, with no significant decline in these measures post-therapy. The study also noted that transgender women's hemoglobin levels remained above the female reference range even after suppression. The authors concluded that 'transgender women who have undergone male puberty retain physical advantages over cisgender women, and these advantages may persist indefinitely,' challenging the assumption that hormone therapy fully mitigates biological differences.

A 2021 study in the International Journal of Transgender Health tracked transgender women undergoing gender-affirming hormone therapy and found that after 12 months of testosterone suppression, muscle mass, grip strength, and hemoglobin levels decreased significantly, falling into the typical female range for many participants. The study reported an average 15% reduction in muscle mass and a 33% reduction in grip strength among participants, with no residual advantage in cardiorespiratory fitness compared to cisgender women. The authors argue that post-puberty hormone therapy effectively eliminates most performance gaps, and that blanket bans based on 'biological advantage' are not supported by longitudinal data.

In June 2023, the International Olympic Committee (IOC) issued new guidelines allowing each sport's governing body to set eligibility criteria for transgender athletes, effectively enabling bans like World Aquatics' 2022 rule. However, a 2023 analysis by Reuters highlighted that there is no peer-reviewed evidence showing that transgender women who have undergone testosterone suppression retain a consistent competitive advantage in elite sport. The IOC's own framework acknowledges that 'no single policy can be universally applied' and calls for decisions based on scientific evidence, which remains inconclusive. Critics argue that bans are driven by moral panic and anecdotal cases (e.g., Lia Thomas), not by data, as fewer than 10 transgender women have competed at elite levels globally in the past decade. The article notes that women's sports face more significant threats from underfunding and abuse scandals than from trans inclusion.